Pharmaron Beijing Co., Ltd. (SHE:300759)

Pharmaron Beijing Revenue

Pharmaron Beijing had revenue of 3.58B CNY in the quarter ending March 31, 2026, with 15.48% growth. This brings the company's revenue in the last twelve months to 14.57B, up 14.73% year-over-year. In the year 2025, Pharmaron Beijing had annual revenue of 14.10B with 14.82% growth.

• Revenue (ttm): 14.57B
• Revenue Growth: +14.73%
• P/S Ratio: 2.91
• Revenue / Employee: 580.94K
• Employees: 25,088
• Market Cap: 42.42B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	14.10B	1.82B	14.82%
Dec 31, 2024	12.28B	737.78M	6.39%
Dec 31, 2023	11.54B	1.27B	12.39%
Jan 1, 2023	10.27B	2.82B	37.92%
Dec 31, 2021	7.44B	2.31B	45.00%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error